BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6943601)

  • 1. [Complement. Evaluation of some complement fractions in patients affected by neoplasia undergoing chemotherapy (author's transl)].
    Ignesti C; Lenzi L; Salvadori D; Innocenti V; Baroncelli C; Casadei BM
    Quad Sclavo Diagn; 1981 Jun; 17(2):152-6. PubMed ID: 6943601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement component analysis in angiodema. Diagnostic value.
    Brasher GW; Starr JC; Hall FF; Spiekerman AM
    Arch Dermatol; 1975 Sep; 111(9):1140-2. PubMed ID: 1167046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of urticaria and acute serum sickness with the C1q precipitin test.
    Lieberman P; Rice MC; Mallette JE
    Arch Intern Med; 1977 Apr; 137(4):440-2. PubMed ID: 139855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
    Santoro F; Bout D; Camus D; Capron A
    Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of some complement components in azoospermic, oligospermic and normospermic Nigerian men.
    Oyeyinka GO; Bello CS; Elegba OY; Nsofor BI
    J Reprod Med; 1987 Oct; 32(10):774-6. PubMed ID: 3500310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes.
    Peake PW; Kriketos AD; Campbell LV; Charlesworth JA
    Int J Obes (Lond); 2005 Apr; 29(4):429-35. PubMed ID: 15111984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial Mediterranean fever, complement, cryofibrinogen, colchicine (author's transl)].
    Wautier JL; Mosesson M; Dervichian M; Cattan D
    Ann Med Interne (Paris); 1981; 132(7):472-4. PubMed ID: 7337322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of circulating immunecomplexes and variations of complement fractions in HBV, HDV and HCV infections: statistical analysis and clinical correlations.
    Riccio A; Reynaud L; Postiglione L; Catalano M; Natale D; Pronestì G; Melfa V; Cicciarello S; Borgia G
    Boll Soc Ital Biol Sper; 1994; 70(8-9):235-42. PubMed ID: 7893482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation in acute coronary syndromes.
    Iltumur K; Karabulut A; Toprak G; Toprak N
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of immunocomplexes and complement in renal transplantation. Preliminary data].
    Schena FP; Pertosa G; Manno C; Losuriello V; Pastore A
    Minerva Chir; 1980 May; 35(10):709-14. PubMed ID: 7005726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complement levels in children with idiophatic nephrotic syndrome (author's transl)].
    Pölz E; Lubec G
    Padiatr Padol; 1977; 12(4):360-4. PubMed ID: 409980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of various fractions of complement (Cl, C3c, C3a, C4) in a population of healthy neonates].
    Zito GA; Grano S; Gallo AB; Papaleo G; Tripodi V
    Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1043-7. PubMed ID: 6982719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-specific changes in the complement system in neoplastic processes].
    Tiagotin IuV; Rybakova LP; Golota GZ; Ishchenko AM
    Vopr Onkol; 2002; 48(2):206-10. PubMed ID: 12227070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
    Stojan B
    Z Rheumatol; 1976; 35(7-8):272-7. PubMed ID: 961078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune complexes and complement in leprosy (author's transl)].
    Geniteau M; Adam C; Verroust P; Pasticier A; Saimot G; Coulaud JP; Languillon J
    Nouv Presse Med; 1981 Dec; 10(45):3697-700. PubMed ID: 7322902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.